Status:

RECRUITING

The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery

Lead Sponsor:

Singapore Eye Research Institute

Conditions:

Fuchs' Endothelial Dystrophy

Cataract

Eligibility:

All Genders

50-100 years

Phase:

PHASE3

Brief Summary

The purpose of this research is to investigate the effects of ripasudil administered as an ophthalmic solution in patients with FED after femtosecond laser assisted cataract surgery. The secondary aim...

Detailed Description

Patients with Fuch's Corneal Endothelial Dystrophy and undergoing femtosecond laser-assisted cataract surgery will be recruited for this study. They will be randomly assigned into treatment or placebo...

Eligibility Criteria

Inclusion

  • Patients with FED who will be listed for cataract surgery as part of standard clinical practice (A cataract will be defined as clouding of the lens that interferes with normal vision).
  • Only patients older than 50 years will be included, as cataracts develops with increasing age. No gender criteria are applied.
  • Ability to provide informed consent, and are willing and able to sign a written Informed Consent Form prior to any study-specific procedures.
  • Patients must be willing and able to return for scheduled follow-up examinations for up to 12 months after the surgery.

Exclusion

  • Patients who are unable to give consent.
  • An only-functioning eye in a patient who has lost visual potential in the contralateral eye.
  • Diagnosis of clinically relevant eye diseases that may interfere with the aim of the study.
  • History of ripasudil use, as well as other systemic disease such as cardiovascular or renal disease.
  • Patients who have previous allergic reactions to the contents present in Glanatec Ophthalmic solution 0.4%

Key Trial Info

Start Date :

March 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2025

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06048380

Start Date

March 1 2025

End Date

July 1 2025

Last Update

January 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Singapore National Eye Centre

Singapore, Singapore, Singapore, 168751